The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorFang Wu
About this trial
To prospectively evaluate the effectiveness and safety of SBRT in the treatment of residual malignant pulmonary nodules after lung cancer, and is committed to providing new treatment options for patients with multiple primary malignant pulmonary nodules who cannot tolerate multiple operations.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- NO Intervention
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Fang Wu
Lead sponsor
Second Xiangya Hospital of Central South University
Sponsor institution
Xiangya Hospital of Central South University
Collaborator
The Third Xiangya Hospital of Central South University
Collaborator
Hunan Cancer Hospital
Collaborator
Source ClinicalTrials.gov